Rawls A, Valdez M R, Zhang W, Richardson J, Klein W H, Olson E N
Department of Molecular Biology and Oncology, Department of Pathology, UT Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA.
Development. 1998 Jul;125(13):2349-58. doi: 10.1242/dev.125.13.2349.
The myogenic basic helix-loop-helix (bHLH) genes - MyoD, Myf5, myogenin and MRF4 - exhibit distinct, but overlapping expression patterns during development of the skeletal muscle lineage and loss-of-function mutations in these genes result in different effects on muscle development. MyoD and Myf5 have been shown to act early in the myogenic lineage to establish myoblast identity, whereas myogenin acts later to control myoblast differentiation. In mice lacking myogenin, there is a severe deficiency of skeletal muscle, but some residual muscle fibers are present in mutant mice at birth. Mice lacking MRF4 are viable and have skeletal muscle, but they upregulate myogenin expression, which could potentially compensate for the absence of MRF4. Previous studies in which Myf5 and MRF4 null mutations were combined suggested that these genes do not share overlapping myogenic functions in vivo. To determine whether the functions of MRF4 might overlap with those of myogenin or MyoD, we generated double mutant mice lacking MRF4 and either myogenin or MyoD. MRF4/myogenin double mutant mice contained a comparable number of residual muscle fibers to mice lacking myogenin alone and myoblasts from those double mutant mice formed differentiated multinucleated myotubes in vitro as efficiently as wild-type myoblasts, indicating that neither myogenin nor MRF4 is absolutely essential for myoblast differentiation. Whereas mice lacking either MRF4 or MyoD were viable and did not show defects in muscle development, MRF4/MyoD double mutants displayed a severe muscle deficiency similar to that in myogenin mutants. Myogenin was expressed in MRF4/MyoD double mutants, indicating that myogenin is insufficient to support normal myogenesis in vivo. These results reveal unanticipated compensatory roles for MRF4 and MyoD in the muscle differentiation pathway and suggest that a threshold level of myogenic bHLH factors is required to activate muscle structural genes, with this level normally being achieved by combinations of multiple myogenic bHLH factors.
生肌碱性螺旋-环-螺旋(bHLH)基因——MyoD、Myf5、肌细胞生成素和MRF4——在骨骼肌谱系发育过程中表现出不同但重叠的表达模式,这些基因的功能丧失突变会对肌肉发育产生不同影响。已证明MyoD和Myf5在生肌谱系早期发挥作用以确立成肌细胞身份,而肌细胞生成素在后期发挥作用以控制成肌细胞分化。在缺乏肌细胞生成素的小鼠中,骨骼肌严重缺乏,但出生时突变小鼠中仍存在一些残留的肌纤维。缺乏MRF4的小鼠是存活的且有骨骼肌,但它们会上调肌细胞生成素的表达,这可能潜在地补偿了MRF4的缺失。先前将Myf5和MRF4无效突变相结合的研究表明,这些基因在体内不具有重叠的生肌功能。为了确定MRF4的功能是否可能与肌细胞生成素或MyoD的功能重叠,我们生成了缺乏MRF4以及肌细胞生成素或MyoD的双突变小鼠。MRF4/肌细胞生成素双突变小鼠中残留的肌纤维数量与仅缺乏肌细胞生成素的小鼠相当,并且来自这些双突变小鼠的成肌细胞在体外形成分化的多核肌管的效率与野生型成肌细胞一样高,这表明肌细胞生成素和MRF4对于成肌细胞分化都不是绝对必需的。虽然缺乏MRF4或MyoD的小鼠是存活的且在肌肉发育中未表现出缺陷,但MRF4/MyoD双突变体表现出与肌细胞生成素突变体类似的严重肌肉缺陷。肌细胞生成素在MRF4/MyoD双突变体中表达,这表明肌细胞生成素不足以在体内支持正常的肌生成。这些结果揭示了MRF4和MyoD在肌肉分化途径中意想不到的补偿作用,并表明激活肌肉结构基因需要一定阈值水平的生肌bHLH因子,而这个水平通常通过多种生肌bHLH因子的组合来实现。